Daclatasvir Daclacure 60 Mg Tablet

Get a Price/Quote

MOQ : 100 Boxes

Daclatasvir Daclacure 60 Mg Tablet Specification

Indication
Chronic Hepatitis C Virus (HCV) Infection

Salt Composition
Daclatasvir Dihydrochloride 60 mg

Dosage Form
Tablet

Enzyme Types
Not applicable (Antiviral Agent)

Feature
Direct-acting antiviral, high cure rate for HCV

Application
Oral use for treatment of Hepatitis C

Physical Color/Texture
Film-coated tablet, appearance may be light to dark color depending on manufacturer

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 Months

Prescription Required
Yes

Pack Size
28 tablets per box (typical packaging)

Marketed In
Worldwide (including Canada, USA, Europe, UK, Australia as evident from image)

Strength
60 mg

Brand Name
Daclacure

Therapeutic Class
Antiviral

Route of Administration
Oral

Daclatasvir Daclacure 60 Mg Tablet Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Daclatasvir Daclacure 60 Mg Tablet About

Get superior antiviral relief with Daclacure (Daclatasvir Daclacure 60 Mg Tablet)-a crowning achievement in chronic Hepatitis C Virus (HCV) therapy. Unlock peerless efficacy with each film-coated tablet, formulated with 60 mg Daclatasvir Dihydrochloride for direct-acting viral suppression. Highly recommended by clinicians worldwide, Daclacure's high cure rate and steadfast quality make it a remarked choice for prescription oral treatment. Each pack contains 28 tablets to support a full course, with worldwide availability in the USA, Canada, Europe, the UK, and Australia. Store below 30C and protect from moisture. Prescription required.

Daclacure 60 Mg Tablet: Targeted Oral Therapy

Daclacure tablets are intended strictly for oral use, providing a practical regimen for patients with chronic HCV infection. Highly recommended for its clinical success, it is used under professional medical supervision. With easy administration and film-coating for gentle swallowing, this product exemplifies convenience and safety, designed for daily oral application during a prescribed course. Its direct-acting mechanism ensures peerless performance in suppressing Hepatitis C virus replication, resulting in optimal treatment outcomes for eligible patients.

Export Market, Certifications, and Sample Policy: Daclacure 60 Mg

Daclacure 60 Mg Tablet maintains a remarked presence in global and domestic mar-including major drop-off regions like Canada, the USA, UK, Australia, and Europe. Sale price transparency is ensured through certified manufacturing practices conforming to international standards. Samples may be available for authorized healthcare providers to facilitate responsible prescribing. Backed by robust certifications, Daclacure is distributed by leading manufacturers, suppliers, and traders from India, meeting diverse global market requirements with seamless logistics and product support.

FAQ's of Daclatasvir Daclacure 60 Mg Tablet:

Q: How should Daclacure 60 Mg Tablet be taken for optimal results?

A: Daclacure 60 Mg Tablet should be taken orally as prescribed by your healthcare provider, usually once daily with or without food, following the full treatment duration recommended for Hepatitis C.

Q: What is the primary benefit of using Daclacure 60 Mg Tablet?

A: The primary benefit of Daclacure is its peerless cure rate and direct-acting antiviral effect against chronic Hepatitis C, leading to a significant reduction or eradication of the virus in eligible patients.

Q: Where is Daclacure 60 Mg Tablet available for purchase?

A: Daclacure 60 Mg Tablet is marketed and available worldwide, including Canada, USA, the UK, Europe, Australia, and through authorized suppliers and traders in India.

Q: When should I start Daclacure 60 Mg Tablet therapy?

A: Initiation of Daclacure therapy should follow a confirmed diagnosis of Hepatitis C infection and upon receiving a prescription from a qualified healthcare provider.